LYNNTECH INC. — Department of Health and Human Services SBIR Phase I: PROJECT SUMMARY This proposal is in response to the NIAID Advanced Technology SBIR (PA-10-
LYNNTECH INC. — SBIR Phase I award from Department of Health and Human Services.
- Amount
- $300,000
- Agency
- Department of Health and Human Services · National Institutes of Health
- Program / Phase
- SBIR · Phase I
- Solicitation
- PA10-123
- NAICS
- —
- Place of performance
- TX
- Period
- —
Description
PROJECT SUMMARY This proposal is in response to the NIAID Advanced Technology SBIR (PA-10-123) Funding Opportunity. This Phase I feasibility study is an advanced technology project with a clearly identified product that will result in a clinically relevanttopical AM treatment modality. The award period and amount requested are guided by project needs and are in compliance with the issued guidelines. Every year, 57 million outpatient surgeries take place in the US, and among these, surgical site infections(SSIs) are the most common nosocomial infection. Studies show that as many as 55% of cases of SSI are preventable and that a reduction in SSI cases can contribute to saving ~4,431 lives and ~ 1.6 billion in healthcare costs, annually. Various measures havebeen implemented however, prevention and treatment of SSI remains a major challenge due to emerging multi-drug resistance. Given the advantages of topical AM therapy in particular (lower costs, reduced potential for systemic toxicity, etc), there is a co